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Pathological effects of herpes simplex virus (HSV) can result due to a combination of direct viropathic effects and
immunological reactions to viral antigens. The immunological reactions are orchestrated by a variety of cytokines and
chemokines released by the host cells. Therefore, the cytokine gene expression in response to HSV-1 infection in a
permissive murine cell line was investigated. The data demonstrate that HSV-1 induced a selective activation of IL-6 gene
expression at the mRNA and protein levels, in the permissive cell line. The cell line used was capable of expressing IL-1,
IL-7, and IL-10 in addition to IL-6, upon lipopolysaccharide stimulation. UV or heat-inactivated viruses were unable to
upregulate IL-6 expression. However, mutant HSV-1 strains lacking fully functional ICP0, ICP4, ICP8, or ICP27 genes, thereby
rendering them replication incompetent or impaired in in vitro cell growth (ICP0), enhanced IL-6 expression selectively.
Considering the role of IL-6 in inflammation, immune response, and its known association with increased levels of MyD116
and GADD 34 mRNAs (genes involved in the prevention of apoptotic death of cells), the present data may have relevance
to HSV-1-mediated diseases as well as to the prevalence of HSV-1 in the host. q 1996 Academic Press, Inc.
Pathological effects of viral infections can result from mucosal surfaces are capable of expressing a variety of
cytokines upon microbial infections (2–5). A recent re-direct damage inflicted on host tissue by the virus or
indirectly by various effector molecules, namely, cyto- view has highlighted the active role of mucosal epithelial
cells in mucosal immune responses, inflammation, im-kines and chemokines, released from host cell in re-
sponse to viral infection. These effector molecules are munoregulation, and microbial pathogenesis (6). In the
present study, the cytokine gene expression in the per-also involved in the orchestration of the immune re-
sponses which could turn out to be protective or patho- missive murine epithelial cell line EMT-6, in response to
HSV-1 (KOS) infection, was analyzed quantitatively usinglogical. The overall outcome of these events could be
beneficial or harmful to the host depending on the milieu quantitative reverse transcription–polymerase chain re-
action (RT–QPCR) and RNA dot-blot hybridization. Therepresented by the cytokines and chemokines mounted.
Virus replication in a cytokine-producing cell, or in certain cell line capable of expressing IL-1, IL-6, IL-7, IL-10,
TNFa, and TGFb showed selective enhanced expressioncases viral products reacting with cells, may serve to
modulate cytokine gene expression (1). Therefore, eluci- of IL-6 (mRNA and protein) upon HSV-1 infection. Mutant
viruses (HSV–KOS) lacking functional ICP27 or ICP8,dation of the molecular events involved in the modulation
of cytokine/chemokine gene expression may help to ma- ICP4, or ICP0 genes also selectively upregulated IL-6
gene expression. The selective upregulation is probablynipulate the immune system to the benefit of the host.
Herpes simplex virus (HSV) can cause tissue damage occurring at the transcriptional level since HSV-1 can
activate NF-kb in the infected cells (7), and the IL-6 pro-directly; however, normally, viropathic and immunologi-
cal reactions to viral antigens mediate HSV pathogenesis moter contains an NF-kb binding motif (8). Enhancement
of mRNA stability brought about by HSV-specific pro-(1). Most frequently herpes viruses gain entry into the
host through mucosal surfaces. Epithelial cells at the tein(s) is another possibility.
In order to study the modulation of cytokine gene ex-
pression by HSV-1, the permissive epithelial-like cell line
EMT-6 derived from murine tissue was used. The EMT-1 Present address: Department of Medicine, North Western Univer-
sity Medical School, 303 East Chicago Avenue, Chicago, IL 60611. 6 cells are totally permissive for productive replication2 To whom correspondence and reprint requests should be ad-
of HSV-1 and takes approximately 18 hr to complete onedressed at Department of Microbiology, M409 Walters Life Sciences
round of replication. The cytopathic effect is almost iden-Building, University of Tennessee, Knoxville, TN 37996-0845. Fax: (615)
974-4007. tical to that observed in Vero or HeLa cells. The virus
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grows to a high titer. This cell line is also used as a target However, they did not have any detectable levels of IL-
2, IL-4, IL-5, IL-12 (40), or IFN-g mRNA. Even though HSV-in demonstrating HSV-1-specific cytotoxic T lymphocyte
activity in vitro. The cells were maintained in Dulbecco’s 1 is known to inhibit host gene expression upon infection
of cells, this effect did not occur with one of a numberminimum essential medium (DMEM) containing 10% fetal
calf serum as well as in serum-free endotoxin-free me- of cytokine mRNA levels quantified. Accordingly, levels
of IL-6 mRNA were elevated 7- to 10-fold in cells infecteddium (Sigma Chemicals, St. Louis, MO). Cytokine gene
expression was studied in response to mock infection, with infectious HSV (Table 1). In contrast, levels of three
other cytokines measured concomitantly in the samelipopolysaccharide (LPS) stimulation, and infection with
live, UV-inactivated, or heat-killed wild-type HSV-1–KOS cells were inhibited, and the expression of IL-10 mRNA
was abrogated totally in cells examined 12 hr postinfec-1.1 and replication-defective mutants derived from KOS
1.1. The mutants used were those lacking functional ICP0 tion (p.i.). The stimulatory effect of HSV-1 infection on IL-
6 gene expression was dependent on virus dose and(9), ICP4 (10), ICP8 (11), or ICP27 (12) genes. All these
mutants have either nonsense mutations or deletions duration of infection (Fig. 1). We further investigated the
possible role played by some of the essential regulatoryand are either totally replication incompetent (ICP4, ICP8,
and ICP27 mutants) or impaired in in vitro cell growth gene products of HSV-1. Accordingly, five mutants defi-
cient for ICP0 (n212), ICP4 (n12), ICP8 (d301), or ICP27(ICP0). Cells were infected with varying multiplicities of
infection (m.o.i.) and for varying periods of time (2, 4, 6, (d27, n504) were used to infect the EMT-6 cell line. The
ICP8 (contains a deletion in the gene) and ICP27 mutantsand 12 hr). LPS (Salmonella typhimurium, Sigma Chemi-
cals) stimulation was carried out by exposing 3 1 106 (either a nonsense mutation n504 or deletion d27) are
capable of expressing the protein products of a, b, andcells/ml to 1.0 mg of LPS for 6 hr. Cells were washed
free of the medium and harvested in TRIZOL reagent g1 genes upon entry into the cells, but they do not repli-
cate and hence are incapable of infecting fresh cells.(Molecular Research Center, Inc., Cincinnati, OH) for
RNA isolation and in eukaryotic lysis buffer (50 mM Tris – The ICP4 mutant (nonsense mutation in the gene) virus
expresses a truncated ICP4 protein (expresses only theHCl, pH 8.0, 150 mM NaCl; 1% NP-40; 0.5% SDS, 1.0 mg/
ml pepstatin, 0.5 mg/ml leupeptin, and 2.0 mg/ml aproti- amino-terminal part of the gene) and, therefore, ex-
presses only a-gene products and hence does not formnin) for protein estimation. Total cellular RNA isolated
was reverse-transcribed using standard protocol (13, 14). infectious virions. ICP0, again, is a deletion mutant and
is impaired in in vitro cell growth. All five mutants, just asA qualitative polymerase chain reaction (PCR) was done
initially using a specific set of primers (13, 14) and subse- the wild-type live KOS, upregulated IL-6 gene expression
selectively while the expressions of two housekeepingquently each message (b-actin, HPRT, IL-1, IL-6, IL-7,
and IL-10) was quantified employing a quantitative com- genes studied (b-actin, HPRT) were downregulated (Ta-
ble 2), the kinetics being similar to that observed withpetitive polymerase chain reaction using a multispecific
internal control (13, 14). The expression of housekeeping the wild-type virus (Fig. 2). The expression of b-actin, IL-
1, IL-6, IL-7, and IL-10 was also analyzed directly by dot-genes (b-actin and HPRT) and various cytokine genes
was also assessed using dot-blot hybridization of spe- blot hybridization of total cellular RNA employing biotin-
labeled specific cDNA probes, and the results (data notcific mRNA using biotin-labeled specific cDNA probes.
The hybridized labeled probes were detected using en- shown) correlated well with the RT–QPCR data and par-
ticularly confirmed the specificity of the PCR reactionshanced chemiluminescent detection system (Photobiotin
Labelling System, Life Technologies, MD). The intensity and products. Having demonstrated the selective upreg-
ulation of IL-6 by HSV, we further tested whether thisof the dots was measured by densitometric scanning
(Model GS-670, Imaging Densitometer, Bio-Rad, Her- indeed translated into a more biologically significant en-
tity, IL-6 protein. Cell (infected with wild-type/KOS ICP4cules, CA). In order to assess the production of IL-6 pro-
tein, the cell lysates (adjusted for cell number and vol- mutant/ICP27 mutant—live or UV-inactivated) lysates
were collected at 2, 4, 6, and 12 hr postinfection andume) were dot blotted on to Nytran membrane
(Schleicher and Scheull, Keene, NH) using a dot-blot ap- tested for IL-6 protein by dot-blot hybridization using
monoclonal antibody raised against murine IL-6. Thereparatus (Bio-Rad Bio-Dot apparatus, Hercules, CA). The
blots were probed with monoclonal antibodies specific were appreciable amounts of IL-6 protein in cell (infected
with live wild type and mutants) lysates collected at 12for murine IL-6 (Pharmingen, San Diego, CA) and bound
antibody was detected by alkaline–phosphatase-conju- hr p.i. with small amounts in sample collected 6 hr p.i.
There were no detectable levels of IL-6 protein in cellgated goat anti-mouse antibody (Sigma Chemicals) and
the substrates BCIP and NBT (Bio-Rad, Hercules, CA). lysates collected at 2 and 4 hr p.i. UV-inactivated viruses
(wild type or mutants) did not induce expression of IL-6EMT-6 cells, grown in growth medium (DMEM con-
taining 10% FBS), expressed various cytokine genes (IL- protein (data not presented).
An HSV-1-induced selective upregulation of IL-6 gene1, IL-6, IL-7, and IL-10) at moderate levels and responded
to LPS (1 mg/ml; 3 1 106 cells/ml) by upregulating the expression (mRNA level and protein level) in a permis-
sive murine epithelial cell line is demonstrated. The lev-expression of all the cytokine genes (data not shown).
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TABLE 1
Cytokine mRNA Levels in EMT-6 Cells in Response to HSV-1 Infection
No. of molecules/10 pgm of total cellular RNA
IL-6 IL-1 IL-7 IL-10
Expt Expt Expt Expt Expt Expt Expt Expt Expt Expt Expt Expt
1 2 3 1 2 3 1 2 3 1 2 3








KOS 595 670 935 760 630 1200 725 695 954 925 1025 695
EMT-6 live
HSV-1–
KOS 3170 2530 5700 110 121 168 112 88 154 10 10 10
Note. The EMT-6 cells were grown in DMEM containing 10% FBS. The cells were infected with an m.o.i. of 5.0. The infection was allowed to
continue for 12 hr. The UV inactivation was achieved by exposing the virus 15 cm away from the source of UV light for 15 min. The virus was heat
inactivated by incubating the virus stock at 567 for 30 min. The total cellular RNA was isolated, quantitated spectrophotometrically, and analyzed
by RT–QPCR.
els of IL-1, IL-7, and IL-10 mRNA were significantly re- the cellular gene transcription during HSV-1 infection,
had implied that the immediate early proteins of the HSVduced along with those of the housekeeping genes b-
actin and HRPT. Previous studies have shown both up- are involved in the upregulation of host gene transcrip-
tion. Kemp and Latchman (21) have indicated involve-and downregulation of expression of various cytokine
genes in monocyte/Mf cells of either murine or human ment of ICP4 proteins in the activation of certain cellular
genes. However, none of the regulatory proteins such asorigin (15 – 17). However, monocytes/Mfs are not fully
permissive for a productive HSV-1 infection and are prob- ICP0, ICP4, ICP8, and ICP27 tested in the present study
seems involved in the enhanced expression of IL-6.ably not the primary targets of HSV-1 infection in the
natural host. HSV infection of a cell is known to shut off There are several transcriptional enhancer elements
present in the 5* flanking region of the IL-6 gene (27). Ahost protein synthesis by the virus host shut-off gene
product (17). There are, however, a few reports in the direct stimulation of IL-6 gene via transactivation by the
HTLV-encoded regulatory protein Tax has been reportedliterature demonstrating upregulation of certain cellular
genes in response to HSV-1 infection (19–22). Another (28). It is also possible that one or more HSV-1-specific
gene product(s) could bind to the IL-6 regulatory ele-herpes virus, namely, human cytomegalovirus (HCMV),
has been shown to be capable of inducing TGFb1 and ments and, thereby, directly influence expression of the
IL-6 gene. Since HSV-1 is able to activate the cellularIL-6 in a human foreskin fibroblast cell line and in bone
marrow cells (23, 24). The exact mechanism(s) involved transcriptional activator NF-kB within the cytoplasm of
infected cells (7), and the IL-6 promoter has the NF-kBin the observed HSV-mediated upregulation of IL-6 gene
expression is not fully understood. However, expression binding motif, HSV-induced upregulation of the IL-6 gene
could be operating through NF-kB activation. Since HSVof some viral genes within the infected cells seems es-
sential since neither the UV-inactivated nor the heat- is capable of upregulating many cellular genes upon in-
fection, it is conceivable that some of these upregulatedkilled virus had any effect. Because UV-inactivated virus
is still capable of interacting with the virus-specific recep- gene products are involved in enhanced IL-6 expression
either through NF-kB activation or directly acting on IL-tor on the host cell surface (25), and it can be internalized,
one can infer that increased IL-6 gene expression is not 6 enhancer elements. The identity of exact HSV proteins
or function of HSV in upregulating various cellular genesa virus–host cell receptor-triggered event. Oakes et al.
(26) have reported the induction of IL-8 gene expression is not yet elucidated. HSV-specific protein(s) could also
increase the stability of the IL-6 mRNA. For example,in human corneal keratocytes only in response to live
HSV-1 infection. Similarly, the TGFb1 and IL-6 in human Mosca et al. (29) have shown that HSV-1 infection can
increase the stability of interferon mRNA.foreskin fibroblast were induced only by live HCMV, not
by UV-inactivated HCMV (23). Everett (19), while studying The biological implications of the present findings are
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FIG. 1. IL-6 mRNA expression in EMT6 cells in relation to m.o.i. and duration of infection. The EMT-6 cells were maintained in DMEM / 10%
FBS. The cells were infected with 0, 0.1, 1.0, 5.0, and 10.0 m.o.i. of HSV-1–KOS. The cells were harvested at 0, 2, 6, and 12 hr postinfection. The
total cellular RNA was isolated and quantified spectrophotometrically. A known amount of total RNA from each sample was then reverse transcribed.
The IL-6 mRNA was then quantified as described in the text by quantitative PCR. The fold increase was calculated based on the value obtained
at 0 hr for each sample.
many. In the murine model of herpetic stromal keratitis in the cornea of BALB/c mice following ocular infection
with live HSV and the mice eventually developed HSK.(HSK), an immunopathological disease, virus replication
is generally restricted to the epithelial layer of the cornea UV-inactivated HSV was incapable of expressing and
maintaining high levels of IL-6 and other chemokines in(Thomas and Rouse, manuscript in preparation). Abun-
dant expression of IL-6 mRNA and protein is observed the cornea and the mice failed to develop HSK (Kanangat
TABLE 2
Housekeeping Gene Expression and Cytokine (IL-6) Gene Expression in EMT-6 Cells in Response to HSV-1 KOS Mutant Strain Infectiona
Number of mRNA molecules/10 pgm of total cellular RNA
b-actin HPRT IL-6
Expt 1 Expt 2 Expt 1 Expt 2 Expt 1 Expt 2
EMT-6 mock 21,462 23,395 15,260 16,950 515 495
EMT-6 KOS
ICP8 mutant 7100 6500 2950 3360 5310 4970
EMT-6 KOS
ICp27 mutant 8700 7900 3100 4350 4420 4755
EMT-6 KOS
ICP4 mutant 8300 7900 3300 4100 4530 6930
EMT-6 KOS
ICP0 mutant 9650 8155 4150 3155 4120 4455
EMT-6 live KOS 6900 8100 2100 3200 6050 7120
Note. The EMT-6 cells were grown in DMEM containing 10% FBS. All four mutants were used at an m.o.i. of 5.0. The infection was continued
for 12 hr. The virus was heat inactivated by incubating the virus stock at 567 for 30 min. The total cellular RNA was isolated and quantified
spectrophotometrically. The mRNAs were quantified by RT–QPCR.
a Heat-killed mutant viruses did not alter the levels of either housekeeping gene expression or the expression of IL-6 gene in EMT-6 cells.
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FIG. 2. Kinetics of IL-6 mRNA expression in EMT-6 cells in response to HSV-1 (KOS) wild-type and mutant strains. EMT-6 cells maintained in
DMEM / 10% FBS were exposed to 5.0 m.o.i. of HSV-1–KOS (wild type) or mutants, namely, ICP8, ICP27, and ICP4. The cells were harvested 2,
4, 6, and 12 hr postinfection, and total cellular RNA was isolated. The RNA was quantified spectrophotometrically. Equal quantities of total cellular
RNA were reverse transcribed, and the IL-6 mRNA was quantified using RT–QPCR (Materials and Methods).
et al., manuscript in preparation). There could be other permissive cell line EMT-6, which is independent of at least
four essential genes of HSV, namely, ICP0, ICP4, ICP8, andchemokines/cytokines that are upregulated upon HSV-1
infection, which might act additively or synergistically ICP27. The system described here will serve as a model to
study the molecular interaction between HSV-1 and hostwith IL-6 and could influence the inflammatory response.
HSV-mediated enhancement of IL-6 expression may also cells with special regard to the expression of various cyto-
kine/chemokine genes involved in the pathophysiology ofbe significant with regard to specific immune responses
generated against HSV since IL-6 is involved in IgA anti- various HSV-mediated disease processes.
body production as well as in early development and
expansion of cytotoxic T cells. The enhanced IL-6 expres-
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